Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines

European Journal of Cancer

Volumn 42, Issue 15, 2006, Pages 2549-2553

  van Dalen, Elvira C ^a   van der Pal, Helena J H ^b   van den Bos, Cor ^a,b   Kok, Wouter E M ^b   Caron, Huib N ^a   Kremer, Leontien C M ^a,b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Anthracyclines; Childbirth; Childhood cancer survivors; Congestive heart failure; Pregnancy

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; RAZOXANE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DELIVERY; EWING SARCOMA; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTHRACYCLINES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; INFANT; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS; SURVIVORS;

EID: 33749133823     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.04.014     Document Type: Article

References (28)

1. Heymans H.S., and Caron H.N. Childhood cancers in the Netherlands (1989-1997). Ned Tijdschr Geneesk 145 (2001) 1442-1444
2. Gatta G., Capocaccia R., Coleman M.P., Ries L.A., and Berrino F. Childhood cancer survival in Europe and the United States. Cancer 95 (2002) 1767-1772
3. Heikens J. Childhood cancer and the price of cure: studies on late effects of childhood cancer treatment. Thesis, University of Amsterdam, Amsterdam; 2000.
4. Kremer L.C., van Dalen E.C., Offringa M., and Voûte P.A. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol 13 (2002) 503-512
5. Kremer L.C., van der Pal H.J., Offringa M., van Dalen E.C., and Voûte P.A. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 13 (2002) 819-829
6. Von Hoff D.D., Layard M.W., Basa P., et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91 (1979) 710-717
7. Lipshultz S.E., Lipsitz S.R., Sallan S.E., et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23 (2005) 2629-2636
8. Shan K., Lincoff A.M., and Young J.B. Anthracycline-induced cardiotoxicity. Ann Intern Med 125 (1996) 47-58
9. Kremer L.C., van Dalen E.C., Offringa M., Ottenkamp J., and Voûte P.A. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol 19 (2001) 191-196
10. Sorensen K., Levitt G.A., Bull C., Dorup I., and Sullivan I.D. Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study. Cancer 97 (2003) 1991-1998
11. Critchley H.O.D., Thomson A.B., and Wallace W.H.B. Ovarian and uterine function and reproductive potential. In: Wallace W.H.B. (Ed). Late effects of childhood cancer (2004), Arnold Publishers, London 225-238
12. Crapo R.O. Normal cardiopulmonary physiology during pregnancy. Clin Obstet Gynecol 39 (1996) 3-16
13. Mone S.M., Sanders S.P., and Colan S.D. Control mechanisms for physiological hypertrophy of pregnancy. Circulation 94 (1996) 667-672
14. Geva T., Mauer M.B., Striker L., Kirshan B., and Pivarnik J.M. Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am Heart J 133 (1997) 53-59
15. Pearson G.D., Veille J.C., Rahimtoola S., et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283 (2000) 1183-1188
16. Green D.M., Grigoriev Y.A., Nan B., et al. Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group. J Clin Oncol 19 (2001) 1926-1934
17. Krischer J.P., Epstein S., Cuthbertson D.D., Goorin A.M., Epstein M.L., and Lipshultz S.E. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol 15 (1997) 1544-1552
18. Silber J.H., Jakacki R.I., Larsen R.L., Goldwein J.W., and Barber G. Increased risk of cardiac dysfunction after anthracyclines in girls. Med Pediatr Oncol 21 (1993) 477-479
19. Katz A., Goldenberg I., Maoz C., Thaler M., Grossman E., and Rosenthal T. Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin. Am J Med Sci 314 (1997) 399-400
20. Davis L.E., and Brown C.E. Peripartum heart failure in a patient treated previously with doxorubicin. Obstet Gynecol 71 (1988) 506-508
21. Van den Bos C., Heinen R.C., Sukel M., van der Pal H.J., and Geenen M.M. Screening for late effects in survivors of childhood cancer: growth hormone deficiency from a pediatric oncologist's point of view. Growth Horm IGF Res 14 Suppl. A (2004) S125-S128
22. Mertens A.C., Yasui Y., Neglia J.P., et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 19 (2001) 3163-3172
23. Le Deley M.C., Leblanc T., Shamsaldin A., et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 21 (2003) 1074-1081
24. Perez D.J., Harvey V.J., Robinson B.A., et al. A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer. J Clin Oncol 9 (1991) 2148-2152
25. Gardner M.J., and Altman D.G. Statistics with confidence (1989), BMJ Press
26. Hanley J.A., and Lippman-Hand A. If nothing goes wrong, is everything alright?. JAMA 259 (1983) 1743-1745
27. Bar J., Davidi O., Goshen Y., Hod M., Yaniv I., and Hirsch R. Pregnancy outcome in women treated with doxorubicin for childhood cancer. Am J Obstet Gynecol 189 (2003) 853-857
28. Siu S.C., Sermer M., Colman J.M., et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104 (2001) 515-521